RoyABeveridgeMD

Oncology • Glen Allen, VA

Chief Medical Officer, Humana

Join to view full profile

Dr. Beveridge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Beveridge's full profile

Already have an account?

Office
4191 Innslake Dr
Glen Allen, VA 23060
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1986 - 1988
University of ChicagoResidency, Internal Medicine, 1983 - 1986
Weill Cornell MedicineClass of 1983

Certifications & Licensure

VA State Medical License 1988 - 2024
MD State Medical License 1986 - 1996
IL State Medical License 1983 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

3 citations
Family Physician Readiness for Value-Based Payments: Does Ownership Status Matter?
Heidy Robertson-Cooper, Bradley Neaderhiser, Laura E. Happe, Roy A. Beveridge> ;Population Health Management. 2017 Oct 1
1 citations
Does a Free Office Visit Affect Primary Care-Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi.
Beech Bm, Tristan Cordier, Laura E. Happe, Trunk L, Gil Haugh, Kwong R, Gopal, Roy A. Beveridge> ;American Health & Drug Benefits. 2017 Apr 1
7 citations
Mortality Differences Between Traditional Medicare and Medicare Advantage: A Risk-Adjusted Assessment Using Claims Data.
Roy A. Beveridge, Sean M. Mendes, Arial Caplan, Teresa L. Rogstad, Vanessa Olson, Meredith Williams, Jacquelyn McRae, Stefan Vargas> ;Inquiry. 2017 Jan 1
The physician-insurer dynamic must shift to successfully implement value-based payments.
Roy A. Beveridge, Laura E. Happe, Mike Funk> ;Healthcare. 2016 Dec 1
1 citations
The path to value through the use of holistic care.
Roy A. Beveridge> ;The American Journal of Managed Care. 2015 Oct 9
The path to value through the use of holistic care.
Beveridge RA> ;Am J Manag Care. 2015-10-01
12 citations
Cost differential by site of service for cancer patients receiving chemotherapy.
Jad Hayes, Russell J Hoverman, Matthew E. Brow, Dana C Dilbeck, Diana K. Verrilli, Jody S. Garey, Janet L. Espirito, Jorge Cardona, Roy A. Beveridge> ;The American Journal of Managed Care. 2015 Mar 1
A conversation with Roy A. Beveridge, MD. Quality, accountability, and leadership.
Roy A Beveridge> ;Managed Care. 2014 May 1
1 citations
Achieving the Meaningful Use Standard: A Model for Implementing Change Within Medical Practices
David C. Fryefield, Stuart Staggs, William Herman, Alan Stickler, Asif Ahmad, Debra A. Patt, Roy A. Beveridge> ;Journal of Oncology Practice. 2014 Mar 1
Achieving the meaningful use standard: a model for implementing change within medical practices.
Fryefield, D. C.,Staggs, S.,Herman, W.,Stickler, A.,Ahmad, A.,Patt, D. A.,Beveridge, R. A.> ;J Oncol Pract. 2014 Mar 19
2 citations
Roundtable--the changing oncology landscape: evolution or revolution?
Roy A. Beveridge, John Fox, Susan A. Higgins, Martin Kohn, John J. Mahoney, Lee N. Newcomer, Andrew von Eschenbach, Clifford Goodman> ;Journal of the National Comprehensive Cancer Network. 2013 May 1
4 citations
Defining Cancer Care Quality or Delivering Quality Cancer Care
Matt Brow, J. Russell Hoverman, Debra A. Patt, Bill Herman, Diana K. Verrilli, Jody S. Garey, Roy A. Beveridge> ;Journal of the National Comprehensive Cancer Network. 2013 Feb 1
1 citations
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report.
Gene Beed, Gary M. Owens, Al B. Benson, Ira Klein, Samuel M. Silver, Roy A. Beveridge, Jennifer Malin, John D. Sprandio, Craig K. Deligdish, Matthew Mitchell, F. Randy...> ;American Health & Drug Benefits. 2012 Jul 1
2 citations
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achiev...
Robert M. Rifkin, Andrew Greenspan, John F. Schwerkoske, Romeo A. Mandanas, Joe Stephenson, George T. Kannarkat, Feng Zhan, Kristi A. Boehm, Lina Asmar, Roy A. Beveridge> ;Investigational New Drugs. 2012 Apr 1
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.
Patt DA, Espirito JL, Turnwald B, Hoverman JR, Neubauer MA, Busby LT, Brooks BD, Kolodziej MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-09-20
37 citations
Benchmarks for value in cancer care: an analysis of a large commercial population.
Michael Kolodziej, J. Russell Hoverman, Jody S. Garey, Janet L. Espirito, Sheetal Sheth, Aimee Ginsburg, Marcus A. Neubauer, Debra A. Patt, Barry Don Brooks, Charles W...> ;Journal of Oncology Practice. 2011 Sep 1
14 citations
Economic impact of disease progression in follicular non-Hodgkin lymphoma.
Roy A. Beveridge, Sacha Satram-Hoang, Kavita R. Sail, Joseph Darragh, Clara Chen, Michael Forsyth, Carolina Reyes> ;Leukemia & Lymphoma. 2011 Oct 24
7 citations
Creating a Process to Standardize Regimen Order Sets Within an Electronic Health Record
Leslie T. Busby, Sheetal Sheth, Jody S. Garey, Aimee Ginsburg, Thomas Flynn, Michael A. Willen, Scott Kruger, Marcus A. Neubauer, Michael A. Kolodziej, David C. Chang,...> ;Journal of Oncology Practice. 2011 Jul 1
Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community.
Patt DA, Espirito JL, Turnwald B, Hoverman JR, Neubauer MA, Cartwright TH, Brooks BD, Busby LT, Sitarik MA, Kolodziej MA, Ginsburg AL, Sheth S, Garey JS, Clayton M, Ne...> ;J. Clin. Oncol.. 2011-05-20
Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.
Neubauer MA, Garey JS, Nelson GC, Patt DA, Cartwright TH, Hoverman JR, Busby LT, Brooks BD, Sitarik MA, Kolodziej MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-05-20
Understanding male breast cancer in the community setting.
Ginsburg AL, Patt DA, Flinn J, Espirito JL, Neubauer MA, Cartwright TH, Hoverman JR, Busby LT, Brooks BD, Kolodziej MA, Sitarik MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-05-20
33 citations
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton, Jody S Garey, Terrance J Kopp, Michael Kolodziej, Marcus A Neubauer, Kathry...> ;Journal of Oncology Practice. 2011 May 1
57 citations
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton, Jody S Garey, Terrance J Kopp, Michael Kolodziej, Marcus A Neubauer, Kathry...> ;The American Journal of Managed Care. 2011 May 1
30 citations
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation
Sergio Giralt, K.F. Mangan, Richard T. Maziarz, J.S. Bubalo, Roy A. Beveridge, David D. Hurd, F.L. Mendoza, E. B. Rubenstein, T. J. DeGroot, M.W. Schuster> ;Annals of Oncology. 2011 Apr 1
85 citations
Integrating Palliative Care Into the Outpatient, Private Practice Oncology Setting
J. Cameron Muir, Farrah Daly, Malene S. Davis, Richard Weinberg, Jessica Heintz, Thomas A. Paivanas, Roy A. Beveridge> ;Journal of Pain and Symptom Management. 2010 Jul 1
Join now to see all

Press Mentions

This AI Startup Raised $43 Million to Save Lives (And Money) by Treating Heart Disease EarlierJune 21st, 2021
Dr. Roy Beveridge Joins Clariifi Managing BoardJune 11th, 2021
Private Investors Pour $25 Million into DME Startup Tomorrow HealthApril 27th, 2021
Join now to see all

RoyABeveridgeMD

Dr. Beveridge is on Doximity

Education & Training

Certifications & Licensure

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.